A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants
PHASE1
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
California Clinical Trials Medical Group/Parexel International
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
PHASE2
To assess the safety, tolerability, biomarker, cognitive, and clinical effi...
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
PHASE1
The primary objective of the study is to assess the safety and tolerability...
Status
Completed
Location
UC San Diego Altman Clinical and Translational Research Insititute Clinic
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
PHASE2
The purpose of this study is to assess the safety, tolerability, biomarker,...